Companies: 10,795·Total market cap: $144.5T

SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc.

SABSNASDAQHealthcare● Active

$3.40

+$0.02(+0.59%)

Market Cap$32497764

P/E Ratio—

52W High$6.6

52W Low$1.6

Avg Volume787K

Open$3.40

Beta0.55

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

SAB Biotherapeutics, Inc.（SABS）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · SABS · 截至 Jun 9, 2026

关键指标

EPS (TTM)—Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)—Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding—Shares outstanding history

Next EarningsTBAEarnings history

探索 SAB Biotherapeutics, Inc. 数据

分析师预测—

股息不分红

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

SAB Biotherapeutics, Inc.

$3.40+0.59%$32.5M #2

AN2 Therapeutics, Inc.

$3.85-0.18%$105.5M #3

Boundless Bio, Inc.

$1.43-1.40%$32.1M #4

Evaxion Biotech A/S

$3.73+0.80%$23.6M #5

Generation Bio Co.

$5.34+0.00%$36.0M #6

Iterum Therapeutics plc

$0.03-10.98%$1.6M

关于 SAB Biotherapeutics, Inc.

CEOSamuel J. Reich

IPO DateFeb 9, 2021

Employees63

CountryUS

Websitesabbiotherapeutics.com

SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing immunotherapies built upon human antibodies. The company leverages sophisticated genetic engineering and ant…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

SAB Biotherapeutics, Inc.（SABS）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 9, 2021 在 NASDAQ 上市。截至最近交易日，SABS 股价为 $3.40，市值约为 $32.5M。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，SAB Biotherapeutics, Inc.（SABS）股价为 $3.40，在 NASDAQ 上市，52周区间为 $1.60 – $6.60。

SABS 最新股价SABS quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议